Brief: Biosergen Q2 EBITDA Loss At SEK 8.0 Mln

Biosergen AB

14/08/2023 08:10

Aug 14 (Reuters) - Biosergen AB  BIOSGN.ST :
    * BIOSERGEN PUBLISHES INTERIM REPORT FOR FIRST QUARTER 2023
    * Q2 EBITDA LOSS SEK 8.0 MILLION VERSUS LOSS SEK 8.0 MILLION
YEAR
AGO
    * Q2 OTHER INCOME SEK 2.5 MILLION VERSUS SEK 1.4 MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr6XNvSt 
Further company coverage:  BIOSGN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))